A carregar...
Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy
PURPOSE: Clinical studies have shown that peroxisome proliferator-activated receptor alpha (PPARα) agonist fenofibrate has therapeutic effects on diabetic retinopathy (DR). The purpose of this study was to identify a novel PPARα agonist and to evaluate its beneficial effects on DR. METHODS: The tran...
Na minha lista:
| Publicado no: | Invest Ophthalmol Vis Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Association for Research in Vision and Ophthalmology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5633008/ https://ncbi.nlm.nih.gov/pubmed/28979999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.16-21402 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|